Update on management of genitourinary syndrome of menopause: A practical guide

Santiago Palacios, Camil Castelo-Branco, Heather Currie, Velja Mijatovic, Rossella E. Nappi, James Simon, Margaret Rees

Research output: Contribution to journalReview article

Abstract

The term genitourinary syndrome of menopause (GSM) emerged following a consensus conference held in May 2013. GSM is a more descriptive term than vulvovaginal atrophy (VVA) and does not imply pathology. However there are concerns that GSM is all encompassing and includes not only symptoms resulting from estrogen deficiency, but also those arising from the effects of ageing and other processes on the bladder and pelvic floor. Focusing on symptoms related to estrogen deficiency, the update provides a practical guide for health and allied health professionals on the impact of GSM on women and their partners, assessment, management and areas for future research. As GSM is a chronic condition, long term therapy is required. Hormonal, nonhormonal, laser and alternative and complementary therapies are described.

Original languageEnglish
Pages (from-to)308-313
Number of pages6
JournalMaturitas
Volume82
Issue number3
DOIs
Publication statusPublished - Nov 1 2015

Fingerprint

Menopause
Estrogens
Health
Pathology
Complementary Therapies
Aging of materials
Lasers
Allied Health Personnel
Pelvic Floor
Laser Therapy
Atrophy
Urinary Bladder
Therapeutics

Keywords

  • Genitourinary syndrome of menopause
  • Menopausal hormone therapy
  • Nonhormonal vaginal therapy
  • Sexuality
  • Vulvovaginal atrophy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Palacios, S., Castelo-Branco, C., Currie, H., Mijatovic, V., Nappi, R. E., Simon, J., & Rees, M. (2015). Update on management of genitourinary syndrome of menopause: A practical guide. Maturitas, 82(3), 308-313. https://doi.org/10.1016/j.maturitas.2015.07.020

Update on management of genitourinary syndrome of menopause : A practical guide. / Palacios, Santiago; Castelo-Branco, Camil; Currie, Heather; Mijatovic, Velja; Nappi, Rossella E.; Simon, James; Rees, Margaret.

In: Maturitas, Vol. 82, No. 3, 01.11.2015, p. 308-313.

Research output: Contribution to journalReview article

Palacios, S, Castelo-Branco, C, Currie, H, Mijatovic, V, Nappi, RE, Simon, J & Rees, M 2015, 'Update on management of genitourinary syndrome of menopause: A practical guide', Maturitas, vol. 82, no. 3, pp. 308-313. https://doi.org/10.1016/j.maturitas.2015.07.020
Palacios S, Castelo-Branco C, Currie H, Mijatovic V, Nappi RE, Simon J et al. Update on management of genitourinary syndrome of menopause: A practical guide. Maturitas. 2015 Nov 1;82(3):308-313. https://doi.org/10.1016/j.maturitas.2015.07.020
Palacios, Santiago ; Castelo-Branco, Camil ; Currie, Heather ; Mijatovic, Velja ; Nappi, Rossella E. ; Simon, James ; Rees, Margaret. / Update on management of genitourinary syndrome of menopause : A practical guide. In: Maturitas. 2015 ; Vol. 82, No. 3. pp. 308-313.
@article{3e39984608fb47bfaacc2f7afd55abb7,
title = "Update on management of genitourinary syndrome of menopause: A practical guide",
abstract = "The term genitourinary syndrome of menopause (GSM) emerged following a consensus conference held in May 2013. GSM is a more descriptive term than vulvovaginal atrophy (VVA) and does not imply pathology. However there are concerns that GSM is all encompassing and includes not only symptoms resulting from estrogen deficiency, but also those arising from the effects of ageing and other processes on the bladder and pelvic floor. Focusing on symptoms related to estrogen deficiency, the update provides a practical guide for health and allied health professionals on the impact of GSM on women and their partners, assessment, management and areas for future research. As GSM is a chronic condition, long term therapy is required. Hormonal, nonhormonal, laser and alternative and complementary therapies are described.",
keywords = "Genitourinary syndrome of menopause, Menopausal hormone therapy, Nonhormonal vaginal therapy, Sexuality, Vulvovaginal atrophy",
author = "Santiago Palacios and Camil Castelo-Branco and Heather Currie and Velja Mijatovic and Nappi, {Rossella E.} and James Simon and Margaret Rees",
year = "2015",
month = "11",
day = "1",
doi = "10.1016/j.maturitas.2015.07.020",
language = "English",
volume = "82",
pages = "308--313",
journal = "Maturitas",
issn = "0378-5122",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Update on management of genitourinary syndrome of menopause

T2 - A practical guide

AU - Palacios, Santiago

AU - Castelo-Branco, Camil

AU - Currie, Heather

AU - Mijatovic, Velja

AU - Nappi, Rossella E.

AU - Simon, James

AU - Rees, Margaret

PY - 2015/11/1

Y1 - 2015/11/1

N2 - The term genitourinary syndrome of menopause (GSM) emerged following a consensus conference held in May 2013. GSM is a more descriptive term than vulvovaginal atrophy (VVA) and does not imply pathology. However there are concerns that GSM is all encompassing and includes not only symptoms resulting from estrogen deficiency, but also those arising from the effects of ageing and other processes on the bladder and pelvic floor. Focusing on symptoms related to estrogen deficiency, the update provides a practical guide for health and allied health professionals on the impact of GSM on women and their partners, assessment, management and areas for future research. As GSM is a chronic condition, long term therapy is required. Hormonal, nonhormonal, laser and alternative and complementary therapies are described.

AB - The term genitourinary syndrome of menopause (GSM) emerged following a consensus conference held in May 2013. GSM is a more descriptive term than vulvovaginal atrophy (VVA) and does not imply pathology. However there are concerns that GSM is all encompassing and includes not only symptoms resulting from estrogen deficiency, but also those arising from the effects of ageing and other processes on the bladder and pelvic floor. Focusing on symptoms related to estrogen deficiency, the update provides a practical guide for health and allied health professionals on the impact of GSM on women and their partners, assessment, management and areas for future research. As GSM is a chronic condition, long term therapy is required. Hormonal, nonhormonal, laser and alternative and complementary therapies are described.

KW - Genitourinary syndrome of menopause

KW - Menopausal hormone therapy

KW - Nonhormonal vaginal therapy

KW - Sexuality

KW - Vulvovaginal atrophy

UR - http://www.scopus.com/inward/record.url?scp=84973477574&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973477574&partnerID=8YFLogxK

U2 - 10.1016/j.maturitas.2015.07.020

DO - 10.1016/j.maturitas.2015.07.020

M3 - Review article

C2 - 26261035

VL - 82

SP - 308

EP - 313

JO - Maturitas

JF - Maturitas

SN - 0378-5122

IS - 3

ER -